Modulators of the glucocorticoid receptor and method

a technology of glucocorticoid receptor and modulator, which is applied in the direction of drug composition, immunological disorders, metabolism disorders, etc., can solve the problem of limited systemic use of the receptor

Inactive Publication Date: 2005-08-04
VACCARO WAYNE +9
View PDF10 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Particularly concerning GR, although glucocorticoids are potent a...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modulators of the glucocorticoid receptor and method
  • Modulators of the glucocorticoid receptor and method
  • Modulators of the glucocorticoid receptor and method

Examples

Experimental program
Comparison scheme
Effect test

preparation 1

2-Amino-4-[1-(4-fluoro)naphthyl]thiazole 1a

[0381]

Step 1

[0382] To a solution of 4′-fluoro-1′-acetonaphthone (28.69 mmol, 5.4 g) in 1,4-dioxane (18.0 mL) at 0° C. was added bromine (35.13 mmol, 5.61 g). After 3 hours at room temperature the reaction mixture was concentrated in vacuo to give 7.66 g (Y: δ 100%) of the product of step 1.

Step 2

[0383] To a solution of the product of step 1 (28.69 mmol, 7.66 g) in ethyl alcohol (20 mL) at room temperature was added thiourea (36.13 mmol, 2.75 g). After 1 hour at room temperature a precipitate formed. To the reaction mixture was added water (100 mL) and the solid was collected by vacuum filtration. The solid was then washed with water (3×100 mL) and dichloromethane (3×100 mL). The solid was then dried in vacuo to give 5.5 g (Y: 75%) of the title compound 1a. MS (E+) m / z: 245 (MH+).

[0384] In a similar manner the following compounds were prepared from the corresponding ketone.

PreparationStructure1b1c1d1e1f1g1h1i1j1k1l1m1n1o1p1q1r1s1t1u...

preparation 2

2-Amino-4-[1-(4-fluoro)naphthyl]imidazole 2a

[0385]

Step 1

[0386] To a solution of the product of preparation 1a, step 1 (18.73 mmol, 5.0 g) in DMF (15 mL) at room temperature was added 1-acetylguanidine (57.43 mmol, 5.80 g). After 5 hours at room temperature, the reaction mixture was diluted with water (100 mL) and extracted with ethyl acetate (3×100 mL). The organic phases were concentrated in vacuo and the residue chromatographed on silica gel (eluted with 5% methanol in dichloromethane) to give 2.0 g (Y: 39%) of the product of step 1. MS (E+) m / z: 270 (MH+).

Step 2

[0387] To a solution of the product of step 1 (7.43 mmol, 2.0 g) in methanol (17 mL) was added water (8.5 mL) and 12 N HCl (12.0 mL). After 1 hour at reflux the reaction mixture was concentrated in vacuo to approximately 15 mL. The resulting solution was then purified and neutralized by cation exchange SPE to give 1.66 g (Y: 99%) of the title compound 2a. MS (E+) m / z: 228 (MH+).

[0388] In a similar manner the followi...

preparation 3

2-Amino-4-(1-naphthyl)oxazole 3a

[0389]

Step 1

[0390] To a solution of 1-acetonaphthone (29.38 mmol, 5.0 g) in glacial acetic acid (10.0 mL) at RT was added bromine (30.06 mmol, 4.80 g) in glacial acetic acid (5.0 mL). After 5 minutes the reaction mixture was poured onto crushed ice and extracted with dichloromethane to give 7.31 g (Y: 100%) of the product of step 1. MS (E+) m / z: 250 (MH+).

Step 2

[0391] To a solution of the product of step 1 (5.50 mmol, 1.37 g) in ethyl alcohol (10 mL) was added urea (27.50 mmol, 1.65 g). After 2 hours at reflux the reaction mixture was concentrated in vacuo and the residue chromatographed on silica gel (eluted with 30% ethyl acetate in hexane) to give 100 mg (Y: 9%) of the title compound 3a. MS (E+) m / z: 211 (MH+).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Poweraaaaaaaaaa
Poweraaaaaaaaaa
Login to view more

Abstract

Novel non-steroidal compounds are provided which are glucocorticoid receptor modulators which are useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes, inflammatory and immune disorders, and have the structure
where Z is CONR1R2 or CH2NR1R2 and where R, Ra, Rb, Rc, Rd, Z, A and B are defined herein.

Description

[0001] This application claims priority from U.S. Provisional Application 60 / 396,877 filed Jul. 18, 2002 which is incorporated herein by reference.[0002] The present invention relates to new non-steroidal compounds which are glucocorticoid receptor (GR) modulators (that is agonists and antagonists) and thus are useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes and inflammatory or immune associated diseases, and to a method for using such compounds to treat these and related diseases. BACKGROUND OF THE INVENTION [0003] The nuclear hormone receptor (NHR) family of transcription factors bind low molecular weight ligands and either stimulate or repress transcription (The Nuclear Receptor Facts Book, V. Laudet and H. Gronemeyer, Academic Press, p 345, 2002). NHRs stimulate transcription by binding to DNA and inducing transcription of specific genes. NHRs may also stimulate transcription by not binding to DNA itself, rath...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/403A61K31/415A61K31/425A61K31/473A61K31/495A61K45/06C07D207/34C07D209/48C07D213/40C07D213/75C07D213/82C07D215/38C07D217/22C07D231/16C07D233/88C07D235/10C07D235/14C07D235/30C07D239/42C07D239/94C07D241/20C07D261/12C07D261/14C07D263/48C07D277/46C07D277/64C07D285/06C07D307/58C07D317/58C07D333/20C07D333/34C07D401/04C07D405/04C07D417/04C07D417/10C07D417/12C07D471/04C07D471/08C07D487/04C07D495/04
CPCA61K31/403A61K31/473A61K45/06C07D207/34C07D209/48C07D213/40C07D213/75C07D213/82C07D215/38C07D217/22C07D231/16C07D233/88C07D235/14C07D235/30C07D239/42C07D239/94C07D241/20C07D261/12C07D261/14C07D263/48C07D277/46C07D277/64C07D285/06C07D307/58C07D317/58C07D333/20C07D333/34C07D401/04C07D405/04C07D417/04C07D417/10C07D417/12C07D471/04C07D471/08C07D487/04C07D495/04A61P1/00A61P1/02A61P1/04A61P1/16A61P1/18A61P11/00A61P11/02A61P11/06A61P11/16A61P13/12A61P17/00A61P17/02A61P17/06A61P17/14A61P19/00A61P19/02A61P19/06A61P19/08A61P21/04A61P25/00A61P27/02A61P27/14A61P29/00A61P3/00A61P3/04A61P31/04A61P35/00A61P35/02A61P37/00A61P37/02A61P37/06A61P37/08A61P43/00A61P5/00A61P7/00A61P7/06A61P9/10A61P3/10A61K2300/00
Inventor VACCARO, WAYNEYANG, BINGWEIKIM, SOONG-HOONHUYNH, TRAMTORTOLANI, DAVIDLEAVITT, KENNETHLI, WENYINGDOWEYKO, ARTHURCHEN, XIAO-TAODOWEYKO, LIDIA
Owner VACCARO WAYNE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products